Fund web.png
Stevie Council_photo.jpg

International Fund for Botanical Drug

 

The International Fund for Botanical Drug (IFBD) is a 501(c)(3) tax exempted nonprofit industry fund to advance research, product development, clinical development, and commercialization of botanical drugs.

Currently, the Fund focuses on developing already-known safe and effective herbal products around the world to botanical drugs in the US, for treating cancer, diabetics, and infectious diseases including Covid.

To donate to ABDA, "Contact US".

Botanical Product Development & Investment Review
115 DAYS TO THE EVENT
The American Botanical Drug Association and entities in Canada, Germany, France, and China combine efforts to identify herbal medicines in disease areas of cancer, diabetics, and infection, including Covid. 28 safe and effective herbal medicine products are on display
When
Sep 09, 9:00 AM – Sep 10, 3:00 PM
Where
Online meeting link sent 1 week before
funding1.jpg

Challenges Facing the Botanical Drug Industry

Pharmaceutical companies have not yet included botanical drugs in their product development.

Some herbal products have been used on markets outside the US for a long time and accumulated sufficient evidence on safety and efficacy. Comparing with pharmaceutical companies, herbal manufactures are smaller and lack funding.

A collective funding mechanism for botanical product development and commercialization is essential for the botanical drug industry.

Operation

With close connections with herbal manufactures worldwide and access to thousands of herbal formulas indicated for many diseases, like cancers, diabetics, and MRSA, ABDA is a platform for all players to work together.

Collectively, the Fund engages scientists and experts and outreaches herbal manufactures for existing promising botanical products. The Fund will then support the botanical drug pre-clinical and clinical development.

funding2.jpg
funding3.jpg

Collective Efforts

In collaboration with research laboratories and institutions in the US, China, Canada, India, Germany, France, and Australia, the Fund identifies safe and effective botanical products suitable for FDA botanical drug investigational new drug development.

Through the mechanism of this Fund, we work together and bring all parties in the complex drug development process to turn ideas to reality. By donating to the Fund, you support the common purpose of bettering lives on earth.